Sernova Biotherapeutics Inc Stock
Stocks
SVA
CA81752F1062
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1350 CAD | +3.85% |
|
0.00% | +3.85% |
| Market Cap | 50.98M 35.86M 31.4M 28.92M 26.85M 3.42B 51.67M 346M 135M 1.68B 135M 132M 5.82B | P/E 2026 * |
-4.5x | P/E 2027 * | -3.38x |
|---|---|---|---|---|---|
| Enterprise Value | 50.98M 35.86M 31.4M 28.92M 26.85M 3.42B 51.67M 346M 135M 1.68B 135M 132M 5.82B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 10.2x |
| Free-Float |
86.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +3.85% | ||
| 1 month | -10.00% | ||
| 3 months | -12.90% | ||
| 6 months | -3.57% | ||
| Current year | +3.85% |
| 1 week | 0.13 |  | 0.14 |
| 1 month | 0.12 | | 0.17 |
| Current year | 0.12 | | 0.2 |
| 1 year | 0.12 | | 0.21 |
| 3 years | 0.12 | | 1.03 |
| 5 years | 0.12 | | 2.22 |
| 10 years | 0.1 | | 2.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Rigby
CEO | Chief Executive Officer | 58 | 12/08/2024 |
James Parsons
DFI | Director of Finance/CFO | 60 | 11/10/2024 |
David Burke
IRC | Investor Relations Contact | - | 11/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
James Parsons
BRD | Director/Board Member | 60 | 19/04/2012 |
Steven Sangha
BRD | Director/Board Member | - | 24/04/2023 |
David Paterson
BRD | Director/Board Member | - | 01/09/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-22 | Option | Chairman | 360,000 | 0.1035% | ||
| 05-22 | Option | Director | 260,000 | 0.0748% | ||
| 05-22 | Option | Chairman | 228,912 | 0.0658% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.85% | 0.00% | -12.90% | -85.94% | 35.86M | |
| +1.51% | +5.42% | -15.44% | +12.79% | 124B | |
| +1.19% | +5.78% | +4.01% | -0.86% | 12.79B | |
| -0.41% | +5.80% | +45.73% | +113.58% | 8.73B | |
| -0.05% | +3.71% | -46.95% | -71.74% | 4.06B | |
| +1.76% | +7.15% | +27.58% | +50.10% | 2.78B | |
| -0.20% | +2.35% | -7.85% | -13.06% | 1.88B | |
| -1.01% | +2.64% | -2.00% | -26.10% | 1.65B | |
| -1.49% | +22.92% | -22.94% | -60.42% | 1.49B | |
| Average | +0.57% | +4.83% | -3.42% | -9.07% | 17.55B | |
| Weighted average by Cap. | +1.28% | -0.63% | -10.38% | +14.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 5M 3.52M 3.08M 2.84M 2.63M 335M 5.07M 33.96M 13.21M 165M 13.21M 12.92M 571M |
| Net income | -12.83M -9.02M -7.9M -7.28M -6.75M -861M -13M -87.11M -33.9M -422M -33.88M -33.13M -1.46B | -19.77M -13.91M -12.18M -11.22M -10.41M -1.33B -20.04M -134M -52.26M -651M -52.22M -51.08M -2.26B |
| Net Debt | - | - |
Employees
8
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/07/26 | CA$0.1350 | +3.85% | 24,204 |
| 03/07/26 | CA$0.1300 | 0.00% | 95,000 |
| 02/07/26 | CA$0.1300 | -3.70% | 60,513 |
| 30/06/26 | CA$0.1350 | 0.00% | 161,770 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1350CAD
Average target price
0.4500CAD
Spread / Average Target
+233.33%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SVA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
